Amesite (AMST) CFO receives 2,500 stock options at $3.05 exercise price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amesite Inc. chief financial officer Sarah Berman reported a compensation-related stock option grant. She received options to buy 2,500 shares of common stock at an exercise price of $3.05 per share, expiring on May 22, 2035. According to the vesting terms under the 2018 Equity Incentive Plan, 25% of the shares vest on May 22, 2026, with the remaining shares vesting in equal monthly installments over 36 months.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Berman Sarah
Role
CHIEF FINANCIAL OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 2,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 2,500 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 2,500 options
Exercise price: $3.05 per share
Underlying shares: 2,500 shares
+2 more
5 metrics
Options granted
2,500 options
Stock Option (right to buy) grant on May 22, 2025
Exercise price
$3.05 per share
Exercise price for options to buy Amesite common stock
Underlying shares
2,500 shares
Common stock underlying the option grant
Expiration date
May 22, 2035
Option expiration under the 2018 Equity Incentive Plan
Initial vesting
25% on May 22, 2026
First tranche of options vesting
Key Terms
Stock Option (right to buy), 2018 Equity Incentive Plan, vested, underlying security
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
2018 Equity Incentive Plan financial
"The option was issued pursuant to the Issuer's 2018 Equity Incentive Plan."
vested financial
"Twenty-five percent (25%) of the shares subject to the option vested on May 22, 2026"
underlying security financial
"underlying_security_title: Common Stock"
FAQ
What did Amesite (AMST) CFO Sarah Berman report in this Form 4 filing?
Amesite CFO Sarah Berman reported receiving a grant of stock options. The award covers 2,500 options to purchase Amesite common stock, issued under the 2018 Equity Incentive Plan with a defined vesting schedule and a $3.05 per share exercise price.
How many Amesite (AMST) stock options were granted to the CFO?
The CFO received 2,500 stock options. Each option represents the right to buy one share of Amesite common stock, giving her the ability to purchase up to 2,500 shares if the options vest and are exercised in the future.
What is the exercise price and expiration date of the Amesite (AMST) CFO’s options?
The options have an exercise price of $3.05 per share and expire on May 22, 2035. This means the CFO can buy shares at $3.05, if vested, any time before the May 2035 expiration date.
How do the Amesite (AMST) CFO stock options vest over time?
Twenty-five percent of the options vest on May 22, 2026, with the remaining shares vesting monthly in 1/36 increments. This creates a multi-year vesting schedule that encourages continued service with Amesite under the 2018 Equity Incentive Plan.
Is the Amesite (AMST) CFO’s Form 4 transaction an open-market stock purchase?
No, this Form 4 reflects a grant of stock options, not an open-market purchase. The options were issued at no cost as compensation, with a $3.05 per share exercise price if the CFO chooses to exercise vested options later.